The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Direxion Daily S&P Biotech Bear 3X ETF (LABD) trades at $7.33, up 3.09% on the day, as of Sep 20, 2026 14:56 UTC.
Direxion Daily S&P Biotech Bear 3X ETF has a market capitalisation of $16.75M, calculated from the live LABD share price and shares outstanding.
Direxion Daily S&P Biotech Bear 3X ETF generated revenue of $0.00 over the trailing twelve months.
LABD has traded between $5.81 and $51.90 over the past 52 weeks, and the last price is 85.9% below that high.
Direxion Daily S&P Biotech Bear 3X ETF is classified under the Financial Services sector and the Asset Management - Leveraged industry, and is domiciled in US.
QFI Terminal shows LABD with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open LABD in Terminal See plans